You are here

Article Text

Article menu
Download PDFPDF
Research letter
A cigar by any other name would taste as sweet
  1. Adrienne S Viola1,
  2. Daniel P Giovenco2,
  3. Erin J Miller Lo2,
  4. Cristine D Delnevo2
  1. 1Rutgers Robert Wood Johnson Medical School & Rutgers School of Public Health, New Brunswick, New Jersey, USA
  2. 2Center for Tobacco Studies, Rutgers School of Public Health, New Brunswick, New Jersey, USA.
  1. Correspondence to Daniel P Giovenco, Rutgers School of Public Health, Center for Tobacco Studies, 335 George Street, Suite 2100, New Brunswick, NJ 08903, USA; d.giovenco{at}rutgers.edu

https://doi.org/10.1136/tobaccocontrol-2015-052518

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In 2009, under the provisions of the Family Smoking Prevention and Tobacco Control Act (FSPTCA), the US Food and Drug Administration (FDA) banned cigarettes with ‘characterising flavours’ like candy, clove and fruit, with the exception of menthol. Importantly, these regulations do not currently apply to cigars, which remain a heavily flavoured market.1 Amid declining cigarette consumption in the USA, cigar sales have risen and prevalence remains high among certain groups. Indeed, among African–American youth, cigars are the most popular tobacco product.2 Moreover, recent studies have shown that young adult cigar smokers have a clear preference for flavoured cigars.1

    We examined trends in flavoured cigar sales between 2008 and 2014 with Nielsen's Convenience Track System data, using previously described methods.1 …

    View Full Text

    Footnotes

    • Twitter Follow Cristine Delnevo at @lozzola

    • Contributors ASV took primary responsibility for data analysis, internet searches and drafting the manuscript. DPG, EJML and CDD contributed to writing and editing the final letter.

    • Funding This study was supported by a grant from the National Institutes of Health, National Cancer Institute (3P30CA072720-17S1).

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.